Survival for patients with resectable lung metastatic colorectal cancer (mCRC). This is an ASCO Meeting Abstract from the 2015 Gastrointestinal Cancers Symposium. This abstract does not include a full ...
Validated processes can often fail during the transfer stage and result in non-value added investment of resources to troubleshoot the problems. Two main reasons for this are; either the variables ...
Dispersion in total cost of care for Medicare fee-for-service (FFS) patients with metastatic pancreatic cancer receiving FDA-approved/NCCN Category 1 regimens at 340B verus non-340B institutions. This ...